Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling medulloblastoma with genetically engineered mice.

Daniel W Fults1

  • 1Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah 84132-2303, USA. daniel.fults@hsc.utah.edu

Neurosurgical Focus
|January 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuro-oncology in the crosshairs during the coronavirus disease 2019 pandemic.

Neuro-oncology practice·2023
Same author

Commentary: Occurrence, Risk Factors, and Consequences of Postoperative Ischemia After Glioma Resection: A Retrospective Study.

Neurosurgery·2022
Same author

Stemming the growth of pediatric gliomas through histone modification.

Neuro-oncology·2021
Same author

Marauding monocytes, macrophages, and microglia in gliomas.

Neuro-oncology·2020
Same author

Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.

Journal of neurosurgery. Pediatrics·2019
Same author

Commentary: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngioma.

Neurosurgery·2018
Same journal

Letter to the Editor. Enhancing comparability in idiopathic intracranial hypertension research through standardized outcome measures.

Neurosurgical focus·2026
Same journal

Introduction. Contemporary spinal arthroplasty.

Neurosurgical focus·2026
Same journal

Cervical disc arthroplasty as a safe and effective procedure for obese patients.

Neurosurgical focus·2026
Same journal

Comparing the operational metrics and functional outcomes of lumbar arthroplasty implants: a systematic review.

Neurosurgical focus·2026
Same journal

Long-term reoperation risk after cervical disc arthroplasty versus fusion: a level-matched meta-analysis of FDA investigational device exemption studies and international randomized trials.

Neurosurgical focus·2026
Same journal

Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials.

Neurosurgical focus·2026
See all related articles

Childhood medulloblastoma arises from cerebellar neural progenitor cells. Mouse models reveal Sonic hedgehog (Shh) and PI3K pathway activation drive tumor formation, offering therapeutic targets.

Area of Science:

  • Neuro-oncology
  • Developmental Neurobiology
  • Cancer Signaling Pathways

Background:

  • Medulloblastoma is a pediatric malignant brain tumor originating in the cerebellum.
  • It is presumed to arise from the transformation of granule neuron precursor cells.
  • In vivo models in mice are crucial for understanding medulloblastoma initiation.

Purpose of the Study:

  • To investigate the signaling pathways that initiate medulloblastoma formation in genetically engineered mouse models.
  • To identify molecular targets for novel therapeutic strategies against medulloblastoma.

Main Methods:

  • Utilized genetically engineered mouse models of medulloblastoma.
  • Analyzed the role of signal transduction pathways, including Sonic hedgehog (Shh)/Patched and phosphatidylinositol 3-kinase (PI3K).

Related Experiment Videos

  • Examined the impact of genetic alterations like p53 inactivation, DNA repair defects, and Myc oncoprotein expression.

    • Main Results:

    • Activation of the Shh/Patched pathway in the postnatal cerebellum is sufficient to induce medulloblastoma in mice.
    • Cooperation between Shh/Patched signaling and other pathways (PI3K, p53 inactivation, Myc) enhances tumor formation.
    • Ectopic expression of interferons can also induce Shh-mediated medulloblastoma, suggesting a role for antiviral responses.

    Conclusions:

    • Mouse models have identified key cell signaling proteins initiating medulloblastoma.
    • Shh/Patched and PI3K pathways are critical in medulloblastoma pathogenesis.
    • Small-molecule inhibitors targeting these pathways represent promising chemotherapeutic agents for medulloblastoma patients.